CLARUS THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Receivables
CLARUS THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Receivables of $2.36 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in receivables for the quarter ending 2022-06-30 was $700.00K, a 30.21% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in receivables for the quarter ending 2022-03-31 was $1.66M, a 101.70% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in receivables for the quarter ending 2021-12-31 was -$591.00K, a 162.28% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in receivables for the quarter ending 2021-09-30 was $704.00K.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in receivables for fiscal 2021 was $1.94M, a 55.89% decline from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in receivables for fiscal 2020 was $4.40M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2022-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $2.36M 10-Q · filed 2022-08-19 | $1.77M derived: sum of 3 quarters · filed 2022-08-19 | $2.48M derived: sum of 4 quarters · filed 2022-08-19 |
| 2022-03-31 | $1.66M 10-Q · filed 2022-05-16 | $1.07M derived: sum of 2 quarters · filed 2022-05-16 | $1.78M derived: sum of 3 quarters · filed 2022-05-16 | $2.78M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-12-31 | -$591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $113.00K derived: sum of 2 quarters · filed 2022-03-31 | $1.12M derived: sum of 3 quarters · filed 2022-08-19 | $1.94M 10-K · filed 2022-03-31 |
| 2021-09-30 | $704.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $1.71M derived: sum of 2 quarters · filed 2022-08-19 | $2.53M 10-Q · filed 2021-11-19 | $3.48M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $1.83M 10-Q · filed 2022-08-19 | $2.78M derived: sum of 3 quarters · filed 2022-08-19 | |
| 2021-03-31 | $825.00K 10-Q · filed 2022-05-16 | $1.77M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $4.40M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $3.45M 10-Q · filed 2021-11-19 |